1. Show article details.

    BRIEF-Thermo Fisher Scientific Prices Offering Of USD-Denominated Senior Notes

    Reuters – 8:46 PM ET 10/19/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER SCIENTIFIC PRICES OFFERING OF USD-DENOMINATED SENIOR NOTES. * ANNOUNCED TODAY THAT IT HAS PRICED AN OFFERING OF $5.85 BILLION AGGREGATE PRINCIPAL AMOUNT OF NOTES. * PRICING OF $1,000,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 18-MONTH FLOATING RATE SENIOR NOTES DUE 2023.

  2. Show article details.

    Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

    PR Newswire – 8:36 PM ET 10/19/2021

    WALTHAM, Mass. The Offering is expected to close on or about October 22, 2021, subject to customary closing conditions. Thermo Fisher intends to use the net proceeds of the Offering to pay a portion of the cash consideration payable for the proposed acquisition of PPD, Inc., a Delaware corporation.

  3. Show article details.

    BRIEF-Thermo Fisher Scientific Announces Offering Of USD-Denominated Senior Notes

    Reuters – 9:19 AM ET 10/19/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER SCIENTIFIC ANNOUNCES OFFERING OF USD-DENOMINATED SENIOR NOTES Source text for Eikon: Further company coverage:

  4. Show article details.

    Thermo Fisher Scientific Announces Offering of USD-Denominated Senior Notes

    PR Newswire – 8:00 AM ET 10/19/2021

    WALTHAM, Mass. Thermo Fisher intends to use the net proceeds of the Offering to pay a portion of the cash consideration payable for the proposed acquisition of PPD, Inc., a Delaware corporation. The joint book-running managers for the Offering are Barclays Capital Inc., Morgan Stanley & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc. and Mizuho Securities USA LLC.

  5. Show article details.

    BRIEF-Thermo Fisher Scientific Inc Says FDA Authorizes New Saliva Sample Collection Method For Automated Covid-19 Testing System

    Reuters – 8:48 AM ET 10/18/2021

    Thermo Fisher Scientific Inc (TMO): * Thermo Fisher Scientific Inc (TMO) - FDA AUTHORIZES NEW SALIVA SAMPLE COLLECTION METHOD FOR HIGH-THROUGHPUT, AUTOMATED COVID-19 TESTING SYSTEM Source text for Eikon: Further company coverage:

  6. Show article details.

    UK Watchdog to Investigate Thermo Fisher's Planned Acquisition of PPD

    DJ Business News – 2:57 AM ET 10/15/2021

    Competition and Markets Authority said Friday that is has started an investigation into Thermo Fisher Scientific Inc.' s planned $17.4 billion acquisition of PPD Inc. (PPD) to see if it would lead to a lessening of competition. The regulator said that it has set a deadline of Dec. 10 for its phase 1 decision. It has also invited comments from interested parties ahead of a further review with a deadline of Nov. 1..

  7. Show article details.

    Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 27, 2021

    PR Newswire – 4:00 PM ET 10/11/2021

    WALTHAM, Mass. During the call, the company will discuss its financial performance, as well as future expectations. About Thermo Fisher Scientific . Thermo Fisher Scientific Inc. (TMO) is the world leader in serving science, with annual revenue of approximately $35 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.

  8. Show article details.

    BRIEF-Thermo Fisher Scientific Prices Offering Of Euro-Denominated Senior Notes

    Reuters – 6:36 PM ET 10/06/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER SCIENTIFIC PRICES OFFERING OF EURO-DENOMINATED SENIOR NOTES. * Thermo Fisher Scientific Inc (TMO) - PRICED AN OFFERING OF EUR 5.25 BILLION OF EURO-DENOMINATED NOTES. * Thermo Fisher Scientific Inc (TMO) - EUR 1.75 BILLION OF 0.800% SENIOR NOTES DUE 2030, PRICED AT ISSUE PRICE OF 99.810% OF THEIR PRINCIPAL AMOUNT Source text for Eikon: Further company coverage:

  9. Show article details.

    Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

    PR Newswire – 6:20 PM ET 10/06/2021

    WALTHAM, Mass. The Offering is expected to close on or about October 18, 2021, subject to customary closing conditions.

  10. Show article details.

    BRIEF-Thermo Fisher Scientific Launches Wastewater Isolation Kit For Sars-Cov-2 Surveillance

    Reuters – 8:52 AM ET 10/05/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER SCIENTIFIC LAUNCHES WASTEWATER ISOLATION KIT FOR SARS-COV-2 SURVEILLANCE Source text for Eikon: Further company coverage:

  11. Show article details.

    Henrietta Lacks' estate says pharma company profited from stolen cells

    Reuters – 3:01 PM ET 10/04/2021

    - The estate of a Black woman whose cervical cells were taken from her decades ago without her permission sued a pharmaceutical company on Monday, saying it made a "conscious choice" to mass produce the cells and profit from a "racially unjust medical system."

  12. Show article details.

    BRIEF-Thermo Fisher Scientific (Finance I) B.V Files Prospectus Supplement Related To Potential Four-Part Euro-Denominated Senior Notes Offering

    Reuters – 8:38 AM ET 10/04/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER SCIENTIFIC B.V FILES PROSPECTUS SUPPLEMENT RELATED TO POTENTIAL FOUR-PART EURO-DENOMINATED SENIOR NOTES OFFERING. * THERMO FISHER SCIENTIFIC B.V- ALL OF OBLIGATIONS UNDER THE NOTES WILL BE FULLY, UNCONDITIONALLY GUARANTEED BY THERMO FISHER SCIENTIFIC INC Source text for Eikon: Further company coverage:

  13. Show article details.

    BRIEF-Thermo Fisher Scientific Opens Biologics Manufacturing Site In Lengnau, Switzerland

    Reuters – 6:24 AM ET 10/01/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER SCIENTIFIC OPENS BIOLOGICS MANUFACTURING SITE IN LENGNAU, SWITZERLAND. * THERMO FISHER SCIENTIFIC (TMO) - LENGNAU SITE WILL BECOME PART OF CO'S GLOBAL BIOLOGICS MANUFACTURING NETWORK, AND APPROXIMATELY 200 EMPLOYEES WILL JOIN CO Source text for Eikon: Further company coverage:

  14. Show article details.

    Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland

    PR Newswire – 6:00 AM ET 10/01/2021

    WALTHAM, Mass. The Lengnau site is a 1.5 million square-foot facility that will leverage highly flexible bioproduction technologies, including both single-use and stainless steel with up to 12,500L bioreactor capacity.

  15. Show article details.

    Thermo Fisher Scientific Continues Support for COVID-19 Testing on Historically Black College and University Campuses

    PR Newswire – 8:00 AM ET 09/29/2021

    WALTHAM, Mass. "A year after we launched The Just Project, COVID-19 cases are increasing again, and testing is critical to ensuring campus safety," said Fred Lowery, senior vice president and president for customer channels at Thermo Fisher Scientific.

  16. Show article details.

    BRIEF-LBT Innovations Ltd Says Signs Distribution Agreement For Apas Independence In U.S. With Remel Inc

    Reuters – 4:18 AM ET 09/27/2021

    LBT Innovations Ltd: * LBT Innovations Ltd - SIGNING OF AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR APAS® INDEPENDENCE IN U.S. WITH REMEL INC., PART OF THERMO FISHER SCIENTIFIC. * LBT Innovations Ltd - LBT'S 50% OWNED JOINT-VENTURE COMPANY, CLEVER CULTURE SYSTEMS HAS SIGNED A FIVE-YEAR AGREEMENT.

  17. Show article details.

    Deutsche Bank hires Citi dealmaker to beef up U.S. healthcare investment banking - memo

    Reuters – 11:08 AM ET 09/24/2021

    Deutsche Bank AG has hired Jorge Barreiro from Citigroup Inc (C) as the managing director for its U.S. healthcare investment banking team, according to an internal memo seen by Reuters on Friday.

  18. Show article details.

    BRIEF-Thermo Fisher Scientific Authorizes $3 Bln Of Share Repurchases

    Reuters – 4:06 PM ET 09/23/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER SCIENTIFIC AUTHORIZES $3 BILLION OF SHARE REPURCHASES Source text for Eikon: Further company coverage:

  19. Show article details.

    Thermo Fisher Scientific Authorizes $3 Billion of Share Repurchases

    PR Newswire – 4:05 PM ET 09/23/2021

    WALTHAM, Mass. About Thermo Fisher Scientific (TMO) Thermo Fisher Scientific Inc. (TMO) is the world leader in serving science, with annual revenue of approximately $35 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.

  20. Show article details.

    BRIEF-Thermo Fisher Expands Capabilities With Its Multichannel Nanodrop Eight UV-Vis Microvolume Spectrophotometer

    Reuters – 8:08 AM ET 09/22/2021

    Thermo Fisher Scientific Inc (TMO): * THERMO FISHER EXPANDS CAPABILITIES WITH ITS MULTICHANNEL NANODROP EIGHT UV-VIS MICROVOLUME SPECTROPHOTOMETER Source text for Eikon: Further company coverage:

Page:

Today's and Upcoming Events

  • Oct
    27

    TMO to announce Q3 earnings (Confirmed)

Past Events (last 90 days)

  • Sep
    14

    TMO ex-Dividend for $0.26 on 09/14/2021

    • Announce Date: 07/08/2021
    • Record Date: 09/15/2021
    • Pay Date: 10/15/2021
  • Jul
    28

    TMO announced Q2 earnings.

Data provided by Thomson Reuters © 2021

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.